Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-04-27

Clinical Trial Update: Metformin for the Treatment of Endometrial Hyperplasia [EARLY_Phase 1]

View source ↗

Summary

An early-phase Phase 1 trial evaluated metformin for treating endometrial hyperplasia and has completed, including cases with and without atypia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • metformin (metformin)

Snippet

Sponsor: UNC Lineberger Comprehensive Cancer Center | Conditions: Endometrial Hyperplasia, Endometrial Hyperplasia Without Atypia | EARLY_Phase 1 | Status: COMPLETED